IMS MIDAS Market Segmentation is a new and powerful global measurement standard enabling rapid, consistent definition of the protected, unprotected and generic pharmaceutical market: Clearer identification of future opportunities; development of more effective product and portfolio strategies and delivery of continued growth.

Click here for the full pdf article.